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Pentoxifylline, a methylxanthine derivative, has been 
shown to inhibit T -cell-mediated cutaneous immune 
response by yet ill-understood mechanisms. Because 
cell adhesion to endothelial cells is a critical step in 
the initiation of such immune responses, we analyzed 
whether pentoxifylline would affect this process. To 
address this issue, adhesion of mouse T -lymphoma 
cells (TK-1) to mouse endothelioma cells (eEnd.2), 
either untreated or stimulated with tumor necrosis 
factor-a (TNFa), was studied. Pentoxifylline reduced 
the ability of endothelioma cells stimulated with 
different concentrations of TNFa, but not of un-
treated endothelioma cells, to bind T -lymphoma 
cells in dose-dependent (10- 5-10-3 M) fashion. Selec-
tive incubation of either endothelioma cells or T-
lymphoma cells revealed that pentoxifylline acted 
exclusively on the endothelioma cells, even when 
added after TNFa stimulation. We questioned 
T -lymphocyte migration across the endothelial ceil lining of microvessels is a central step dur ing the initiation of inflammatory response in skin [1] . Before T cells can pass from the circul ation into tissues they have to bind to endothelial cells. T his contact is 
established by the interaction of ceil adhesion molecules (CAMs) 
on T lymphocytes and endotheli al cells [1-3]. 
A model postulating multiple steps for lymphocyte adhesion has 
been proposed (reviewed in [2,3]). The fi rst step in the adhesion 
sequence is a random collision of lymphocytes and endothelium 
resulting in weak unstable binding, mediated by CAMs of the 
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whether pentoxifylline suppressed T -lymphoma celli 
endothelioma cell interactions by interfering with 
adhesion molecules expressed by either cell. How-
ever, as determined by flow cytometry, pentoxifylline 
did not alter TNFa-induced upregulation of intercel-
lular adhesion molecule-lor vascular cellular adhe-
sion molecule-ion endothelioma cells nor did it 
affect constitutive CDl1a, CD18, or a4-integrin ex-
pression on T -lymphoma cells, suggesting that rather 
than affecting quantitative expression of these adhe-
sion molecules, pentoxifylline might modulate their 
avidity. We conclude that pentoxifylline in therapeu-
tically achievable concentrations is a potent inhibitor 
of TNFa-induced T -lymphoma cell adhesion to en-
dothelioma cells. This finding may account, at least 
in part, for the recently discovered anti-inflamma-
tory action of pentoxifylline. Key words: T cellslcell-
adlaesioll 1I101emles. ] Invest Dermatol 104:824-828, 1995 
selectin group or by CD44 [1-3]. Subsequently a strong adhesion of 
T cells to endothelia.! cell s is triggered by signals activating T-cell 
integrin function. TIllS is m ediated by interaction of the adhesion 
molecules intercellul ar CAM-1 (rCAM-1) and vascu.!ar CAM-1 
(VCAM-1 ) on endothelial cells and lymphocyte function associated 
antigen-1 (LFA-l) (i.e., the CDlla/CD18 heterodimer) and very 
late antigen-4 (VLA-4) on T ceils [1-3]. Knowledge of the exact 
mechanisms that govern these interactions is important for devel-
oping therapeutic modalities capable of interfering with the migra-
tion of T cells into tissues. 
Pentoxifylline (PTX) , a xantlline derivative [4], has recently 
been demonstrated to suppress T - cell-mediated cutaneous immune 
response such as irritant and contact hypersensitivity (CHS) in mice 
[5] . Although this effect is still ill understood, it has been hypoth-
esized that PTX could suppress T - cell-endothel.ial ceil inte ractions 
[5] . Here we report that PTX in therapeutically re levant concen-
trations inhibits tumor necrosis factor (TNFa)-induced adhesion of 
T cells to endothelial ceUs by acting selectively on the endothelial 
cells. 
MATER.JALS AND METHODS 
Cells T he mouse lymphoma cell I.ine TK-1 was a gift of Dr. Dcrnl1ard 
Holzmann (KJinikum R cchts der Isar, Miinchcn, F.R.G.) [7] . T he mouse 
endothe lioma cell line cEnd.2 establ.ished from polyoma-induced hcmangi-
0022-202X/95/S09.50 • SSDJ0022-202X(95)00028-j • Copyri ght © 1995 by T he Society for Investigative Dermatology, Inc. 
824 
VOL. 104, NO. 5 MAY 1995 PENTOXYFILLlNE INHmlTS T-CELL ADHESION TO ENDOTHELIAL CELLS 825 
omas in the mouse embryo has been described previously [8]. Both cell lines 
were cultured as described [9,10] . 
Antibodies and Reagents The rat MoAb YN1I1.7 anti-mouse 
ICAM-1 IgG2b (MALA-2) [6] was a gift of Dr. Fumio Takei (British 
Columbia Research C enter, Vancouver, BC, Canada) . Rat anti-mouse 
ICAM-1 MoAb 16AE12 and 25ZC7 were generated by M. Halme and D . 
Vestweber [9]. Rat anti-mouse VCAM-1 4EE6 (lgM) and 16HB5 (IgG2a) 
[9,10] were raised against murine VCAM-1. All MoAbs were shown to bind 
specifically to TNF-induced ICAM-l or VCAM-1 on endothelioma cells 
[10] . Anti a4-integrin, rat MoAb PS/2 (lgG2b/K) [11], and anti-mouse 
LFA-l rat MoAbs M17/4.2 (anti-COlla, IgG2b) and M1812 (anti-CD18, 
IgG2a) were all obtained from the American Type Culture Collection 
(Rockville, MD) . Fluorescein isothiocyanate (FITC)-conjugated affine 
pure F(ab ' )2 fragment goat anti-rat (H + L) MoAb was purchased from 
Jacksollimmunoresearch Laboratories , W est Grove, PA. Pentoxifylline was 
obtained from Hoechst AG, Wiesbaden, F.R.G., and was used 10- 5_10 - 3 
M in all experiments. 
Cell Viability eEnd.2 and TK-1 cells were incubated in medium con-
taining PTX (10 - 5_10- 3 M) for 16 h or 20 min, respectively. Mter 
extensive washing the vital dye propidium iodide (PI) (Sigma, St. Louis, 
MO) was added (1 /Lg/ml) and the percentage of viable cells was 
detemlined by FACScan, Becton Dickinson Immunocytometry Systems, 
Heidelberg, F.R.G.), analyzing 10,000 cells/sample. Altematively, 2 X 10· 
eEnd.2 or TK-1 cells were plated in flat-bottom 96-well microtiter plates 
(Greiner, Nurtingen, F.R.G.), cultured for 24 h and then exposed selec-
tively to PTX (10 - 5_10- 3 M) for 16 h or 20 min, respectively. Controls 
were left untreated. For the final 12 h of culture, cells were pulsed with 
1 /LCi/ weli 'of methyl-[3H]-TdR (Amersham, Braunschweig, F.R.G.). 
Culturcs were thcn collected onto nitrocellulose filter paper (Canberra 
Packard, Frankfurt, F.R.G.) using a Packard Harvester (Canberra Packard). 
Incorporated [3H]_ TdR was determined in a liquid scintillation counter 
(Top Count, Canberra Packard). 
Adhesion Assay Adhesion assays were performed as described previ-
ously [9], in brief as follows. Confluent eEnd.2 endothelioma cells (96-well 
flat-bottom microtiter plates, Greiner) were stimulated with recombinant 
murine TNFa (125-500 V / ml, Genzyme Corporation, Cambridge, MA) in 
the presence or absence ofPTX (10- 5-10- 3 M) for 16 h at 37°C and 5% 
CO2 , eEnd.2 cells, PTX untreated, in the presence or absence of TN Fa, or 
treated with PTX (in the absence of TN Fa) served as controls. Following 
tlus treatment, eEnd.2 cells were washed extensively. TK-l suspended in 
Hanks' buffered saline solution with Ca2+ and Mg2+ (Gibco), treated ,vith 
or without PTX (10- 5-10 - 3 M) were added (5 X lOS/well) for 20 min at 
37°C and 5% CO2, Altematively, eEnd.2 (16 h, 37°C, 5% CO2) or TK-l 
(20 min, 37°C, 5% CO2) cells were PTX treated separately prior to 
co-incubation. No PTX was present during the co-incubation. ICAM-1-
inlubition studies were perfonned as described previously [9]. Subsequently, 
unspecifically binding TK-1 cells were removed by upsidedown centrifu-
gation of sealed plates, 30 seconds, 1000 rpm, 4°C. Wells were then washed 
twice with Hanks ' buffered saline solution and specifically adhering TK-1 
were counter-stained with 0.5% thiOlun acetate (Sigma, St. Louis, MO) in 
20% ethanol for 20 seconds and then washed with distilled water. Prior to 
analysis, the different experimental groups, all perfonned in triplicate, were 
coded. TK-1 binding was detemlined by two independent investigators as 
described [9], by counting tune random fields/well under an inverted 
microscope (IMT-2, Olympus, Dusseldorf, F.R.G.) using an optical grid 
(Olympus) at lOX magnification, followed by calculation of average TK-l 
adhesion/mm2 . Data arc expressed as specifically adherent TK-1/mm2 :!: 
SO of triplicate measurements . 
Statistical Analysis DiJferences in the mean valucs among treatmcnt 
groups were detemlincd with the Dunnett test. 
Irnmunostaining and Flow Cytometry Seventy percent confluent 
eEnd.2 were incubated in complete Dulbecco's modified Eagle's medium 
(DMEM) with or without TN Fa (500 V / ml) and PTX (10- 5-10- 3 M). 
After 16 h cells w ere washed twice, detached Witll trypsin/ethylenedianu-
netetraacetic acid (EDTA) (Gibco) and resuspended in 0.01 % sodium azide 
in phosphate-buffered saline (PBS) . TK-1 cells were incubated in completc 
RPMI 1640 containing PTX (10- 5_10- 3 M) for 20 min. C ells wcre 
incubated with primary MoAb for 20 min at 4°C, washcd, and then stained 
with appropriate FITC-labeled secondary antibodies. Cells were analyzed 
immediately in a FACScan (Becton Dickinson) equipped with tile FACScan 
Research Software (Bccton Dickinson), excluding dead cells by propidium 
iodide (1 /Lg/ml). 
Figure 1. PTX reduces TNFa-stimulated TK-l adhesion to eEnd.2. 
Adhesion assays were perfonned as described in Materials alld M et/rods (55 X) . 
Left. constitutively binding TK-l after 20 min co-incubation (37°C, 5% 
CO2) with untreated eEnd.2. C ellte,., eEnd.2 were stimulated with 500 
V/ml of TN Fa (16 h, 37°C, 5% CO2) prior to co-incubation with TK-1 (20 
min, 37°C, 5% CO2), Right, eEnd.2 were stimulated with TNF (500 V, 16 
h, 37°C) in the presence of PTX (10 - l M). PTX was present tluoughout 
co-incubation. 
RESULTS 
PTX Dose-Dependendy Inhibits TNFcx-Induced TK-l Ad-
hesion to eEnd.2 In the first set of eX"}Jerimcnts PTX was added 
to eEnd.2 during the entire TNFa stimulation and was also present 
throughout the assay with eEnd.2 and TK-1. TNFa markedly 
increased the capacity of eEnd.2 to bind TK-1 when compared to 
wltreated controls (Figs 1 and 2a). PTX reduced this adhesion in 
concentration-dependent fashion with maximum inhibition at PTX 
10- 3 M (p < 0.05) (Figs 1 and 2a, Table I). PTX reduced TK-1 
binding to eEnd.2 treated with clliferent concentrations of TNFa 
(125,250,500 U/ml). Maximum inhibitory effects ofpentoxifylline 
were seen after stimulation ofeEnd.2 with 500 U / ml TNFa (Table 
I). However, PTX did not inhibit TNFa-independent TK-1 adhe-
sion to untreated eEnd.2 (Fig 2b). 
To investigate whether PTX acted primarily on eEnd.2 or on 
TK-1 cells, both cell lines were incubated separately with PTX 
prior to the assay. Selectivc PTX treatment of eEnd.2 during TNFa 
stimulation resulted in statistically significant (p < Q.05) , dose-
dependent inhibition of TK-1 adhesion (Fig 2c). This was also 
observed whcn PTX was added after 16 h TNFa stimulation of 
eEnd.2 (Fig 3) . By contrast, a selective incubation ofTK-1 had no 
effect on their adhesivc propcrtics (Fig 2tf). 
PTX Does Not Affect Adhesion Molecule Expression on 
eEnd.2 or TK-l MoAb blocking studies dcmonstrated that 
TNFa-induced adhesion of TK-1 to eEnd.2 is mediated by inter-
action of ICAM-1 and VCAM-1 (on eEnd.2) with their ligands 
LFA-1 and VLA-4 (on TK-1) (Fig 4 and [9]). In contrast, 
constitutive binding of TK-l to eEnd.2 could not be inhibited by 
ICAM-1 MoAb YN1.1/7 (Fig 4) or VCAM-1 MoAb 4EE6 (data 
not shown). To test whether PTX reduced TK-l adhesion to 
eEnd.2 by modulating the TNFa-induced surface expression of 
these molecules, we measured dle level of ICAM-l and VCAM-l 
on TNFa-stimulated eEnd.2 cells, treated with PTX. By analogy, 
constitutive expression of their ligands LFA-l (i .e., CDlla/ CD18) 
and a4-integrin on TK-l was analyzed after selective PTX incu-
bation. TN Fa stimulation of eEnd.2 resulted in strong ICAM-1 
augmentation as detemlined widl three clliferent anti-ICAM-l 
MoAbs recognizing clliferent epitopes, YN1.1/7 (Fig 5), 16AE1 2, 
and 25ZC7 (data not shown). Addition of PTX (10 - 3 ) did not 
affect this ICAM-1 upregulation (Fig 5) nor did it alter constitutive 
ICAM-1 eX"}Jression on wlstimulated endothelial cells (data not 
shown). Similarly, PTX did not influence TNFa-induced upregu-
lation of VCAM-l on eEnd.2, as determined by MoAb 4EE6 and 
16HB5 (data not shown). Finally, PTX had no effect on constitutive 
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Figure 2 . PTX reduces the ability of TNFa-stirnulated cEnd.2 to bind TK-l in a concentration-dependent fashion. TK-l adhesion to 
w1stimulated or TN Fa-stimulated eEnd .2 (500 U/ml T N Fa, 16 h , 37°C, 5% CO2) was measured as described in Materia ls mill Mellt"ds (cells/mm2, mean :':: 
SO of three wells) : PTX at the indicated concentrations was added during TNFa stimulation ofeEnd.2 and during co-incuba tion with TK-1 (20 min, 37°C, 
5% CO2) (A). Unstimulated eEnd.2 cells were treated with PTX (16 h at 37°C, 5% CO2) prior to co-incubation with TK-l in presence ofPTX (8) . Selec tive 
PTX incubation of eEnd.2 during T NFa stimulation . Twenty-minute co-incubation was p erformed in the absence of PTX (C). Selective PTX incubation 
(20 min, 37°C, 5% CO2 ) of TK-1 cell s prior to 20 min co-incubation with TNFa-treated or -untreated eEnd. 2 in the absence of PTX (D). 
LFA-l (CD11a and CD18) and a 4- integrin expression by TK-l 
cells as de termined by MoAb M 17 I 4.2, M1812, and PSI2 (data not 
shown) . 
DISCUSSION 
PTX is a drug with well established hemorrheologic function that 
has been used for the trea tment of vascular disorders for over a 
decade [4]. Previously PTX has been shown to suppress TNFa 
mRNA production by leukemia cells [12] and to inhibit the 
inflammatory action of T N Fa and interleuki.n-1 on human neutro-
phils [13] . The substance has also been demonstrated to reverse 
effects of exogenously added TNFa on PMN such as adhesion to 
plastic dishes, polymorphonuclear le ukocyte (PMN) migratory 
suppression, and CD11b antigen expression [14). 
Tllis study reports a new function ofPTX by demonstrating that 
the drug at therapeutically achievable levels inllibits TNFa-induced 
T-cell adhesion to endothelial cells. Inllibition occurs in a concen-
tration-dependent fasllion with a maximum effect at 10 - 3 M . Tllis 
is strictly dependent on exogenously added T N Fa (1 25-500 U/m!, 
with maxima] inhibition at 500 U / ml); importantly, PTX did not 
Table I. PTX Affects TK-l Adhesion to eEnd.2 Induced by Different Concentrations of TNFa 
~-Binding TK-l n 
TNFa + PTX T NFa + PTX TNFa + PTX 
T NFa 10- 5 M 10- 4 M 10- 3 M 
500 U T N Fa 608 :':: 20 549 :':: 28/' 472 :':: 18/' 193 :':: 34/' 
250 U TNFa 591 :':: 20 557 :':: 34 465 :':: 31" 184 :':: 26" 
125 U TNFa 344 :':: 35 312 :':: 16 293 :':: 29 149 :':: 23 /' 
If Adhesion assays were pe rformed as described in Materials aud Methods. PTX was present during TNFcx-stlmulation and co-incubadon. Mean ± SD of bindi ng TK-1/ 1ll1112 or 
three wells was ca lcul ated. Do-binding TK- l was calculated by subtracting the number ofconstituti vcl y bound TK- l fro lll the number of adhering TK- l after TNFo-stimulation 
ill the presence or absence o f PTX. 
b Statistica lly significant difference of treatment group compared to TNPo-activated/PTX untreated group (p < 0.05). 
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Figure 3. PTX treatment of eEnd.2 after TNFa stimulation inhibits 
TK-l binding. TK-l adhesion to unstimulated or T N Fa -stimulated 
eEnd. 2 (500 U/ ml T NFa, 16 h, 37°C, 5% CO2) was evaluated (cells/nun2, 
mean ::': SD of three wells) as described in Mate,.ials alld IIfethods. PTX at the 
inetica ted concentrations was added immediately after T NFa -stimulation of 
eEnd.2 for 1 h (37°C, 5% CO 2) , T he substance was not present during 
co-incubation with TK-l (20 min , 37°C, 5% CO 2), 
alter constitutive TK-1 adhesion to unstimulated EC. PTX acted 
exclusively on endothelial cells and not on T cells as shown by 
selective in cubation of either TK-1 or eEnd .2. Inhibition of TK-1 
adhesion was not due to cytotoxic effects of PTX on eEl1d. 2 or 
TK-1 as demonstrated by viability stainings and by proliferation 
assays (data not shown). 
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Figure 4. TNFa induced, bnt not constitutive, adhesion ofTK-l to 
eEnd.2 is inhibited by anti-ICAM-l MoAb. Cell adhesion assays were 
perfo rmed as described in Materials alld M ethods with unstimulated or 
TN Fa-stimulated (500 U/ ml , 16 h , 37°C, 5% CO2 ) eEnd.2. TK-l binding 
to T N Fa-stimulated eEnd.2 cell s was defined as 100%. Ten micrograms per 
milliliter of purified MoAb YNlIl. 7 (anti lCAM-l) or 10 J.Lg/ ml rat Jg 
were added for 30 min (37°C) prior to 20 min co-incubation with TK-l . 
ICAM-l 
-
logFL 1 
control 
TNF-alpha 
PTX 10-1 M 
+TNF-alpha 
Figure 5. PTX does not alter TNFa-induced upregnlation of 
ICAM-l on eEnd.2 cells. eEnd.2 cells were stimulated with TN Fa (500 
U / ml) in the presence of PTX (10- 3 M) for 16 h (37°C, 5% CO 2), 
Subsequently cells were stained with anti-ICAM-l , MoAb MALA- 2, and 
appropriate secondary FlTC-labeled antibodies, then 10,000 cells were 
analyzed by Row cytometry as described. 
To this date, little is known about the effects of PTX on tlle 
adhesion of T cells to endotllelial cells. In a preliminary report, an 
inhibitory effect of PTX on PMN adhesion to interleulcin-1-
activated human umbilical vein endothelial cells was described [15] . 
Furthermore, PTX was reported to inhibit T -lymphocyte binding 
to activated keratinocytes . t In the present study we confirmed that 
T N Fa-augmented adhesion ofTK-1 to eEnd. 2 cells is mediated by 
the interaction ofICAM- l and VCAM-1 on eEnd.2 and LFA-1 and 
a4-integrin on TK-t [9,10]. W e questioned whether PTX sup-
pressed T cell-endothelial cell adhesion by modulating tllese 
molecules. However, PTX did not affect T N Fa-induced TCAM- 1 
and VCAM-1 expression or constitutive LFA-1 (CD11a/CD11b, 
CD18), a4-integrin expression on TK-l. We could also exclude 
that PTX affected E- and P-selectin-mediated TK-1 binding, 
because these CAMs are no longer ell:pressed 16 h after TNFa 
stimulation [9] . 
PTX has been shown to downreglliate constitutive and fomlyl-
methionyl-leucyl-phenylalanine-stimlllated expression of CDt1a 
and CD18 on human granulocytes [1 6] and recombinant human 
(rh)TNF-augmented CD1t a expression on human PMNs [14] . 
T his is in contrast to our own results that failed to detect an effect 
0 1) TN Fa-induced TCAM-I , VCAM-I (on elldotllelial cells), or 
consti tutive CDlla, CD18, or a -4-integrin expression (on T cells). 
T hese discordant findings may refl ect differences in PTX dosage, 
i.e., Boogaerts ef ti l [1 6] and Salyer et til [14] employed much higher 
PTX concentrations, which are not achievable ill v illO during 
treatment. Roberts ef ai , using PTX doses identical to ours, fail ed to 
detect signiflc3nt PTX effects on FMLP-induced CD1t b on gran-
ulocytes [17] tllereby supporting our finding tllat PTX at tllerapeu-
tically achievable doses does not affect the quantitative expression 
of CAM. 
Instead we speculate that PTX modifies the function of tllese 
CAM on endothelial cells . It is known that cell adhesion is not only 
dependent on upregulation of CAM expression but also on their 
association with the cell cytoskeleton (reviewed in [18 ,3]) and on 
the ir capping and clustering on the m embrane [19]. T hese processes 
are Cl;tiCally dependent upon membrane fluidity and cell cytoskel-
eton polymeriza tion [20]. We posit that PTX alters endothelial cell 
t Bruyn zeell , van der R.aaij LMH, StoofTJ , Willem ze R . Pentoxifylline 
inhibits T lymphocyte/ keratinocytc billeting (abstr). J IlIlfcst Dentlarol 100: 
439, 1993. 
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membrane fluidity thereby interfering with ICAM-l clustering and 
capping because 1) a short exposure ofPTX was sufficient to reduce 
the capacity of TNFa-treated eEnd.2 to bind TK-1 and 2) mem-
brane properties of leukocytes and erythrocytes have been shown 
to be profoundly affected by PTX [4 ,21]. Furthermore, PTX 
depolymerizes the cytoskeletal component actin and thereby inhib-
its capping in PMN and lymphocytes [22]. Previously it has been 
demonstrated that disruption of micro filaments changed the local-
ization of CAMs such as ICAM-1 [23]. Therefore it is intriguing to 
hypothesize that the inhibition of T-cell adhesion to endothelial 
cells by PTX could be facilitated by preventing TNFa-induced 
CAM clustering on endothelial cells. 
We conclude that PTX, at clinically achievable concentrations, 
inhibits TNFa-augmented adhesion of TK-1 lymphoma cells to 
eEnd.2 endothelioma cells, by acting selectively on the endothelial 
cells. Our results raise the possibility that PTX could prove an 
important therapeutic substance in inflammatory responses requir-
ing T-cell transmigration through a layer of cytokine-activated EC. 
In fact, PTX has recently been shown to suppress irritant and 
contact hypersensitivity reactions in mice [5]. Based on our find-
ings, these anti-inflammatory effects of PTX can at least in part be 
explained by the drug's suppressive effect on T-cell-endothelial 
cell interaction. 
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